title: Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep.
abstract: Ricobendazole (RBZ) was administered in sheep at the dose rate of 5 mg/kg by intravenous (i.v.) route as a 10% experimental solution, by the intraruminal (i.r.) route as a 10% experimental suspension, and by the subcutaneous (s.c.) route as a 10% commercial formulation available in Argentina. Blood samples were drawn during a 60 h period. Plasma concentrations of RBZ and its inactive metabolite albendazole sulphone (ABZSO2) were determined by high-performance liquid chromatography. The pharmacokinetic parameters were determined by compartmental analysis. The fitting of the data was done by weighted least-squares non-linear regression analysis. The pharmacokinetic parameters were estimated for every animal by simultaneous fitting of the plasma concentrations profiles of RBZ obtained after its administration by the three routes. The kinetic analysis of ABZSO2 was performed by a statistical moment approach. Ricobendazole bioavailability was poor after i.r. administration, whereas high and sustained plasma concentrations and higher bioavailability were obtained after s.c. administration. A simple two-compartment open model explains in a mechanical sense the pharmacokinetic behaviour of RBZ in sheep and allows us to estimate the real first-order constant rate of absorption and the loss of drug from the absorption site after its administration by s.c. and i.r. routes.
authors.affiliation: Cátedra de Farmacología, Facultad de Ciencias Veterinarias, Universidad Nacional del Litoral, RP Kreder 2805, Esperanza (3080), Argentina. eforment@fcv.unl.edu.ar
authors.forename: E A
authors.initials: EA
authors.lastname: Formentini
authors.forename: N
authors.initials: N
authors.lastname: Mestorino
authors.forename: J O
authors.initials: JO
authors.lastname: Errecalde
mesh_terms: D015766:Albendazole / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000097:blood / Q000493:pharmacokinetics; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage* / Q000097:blood / Q000493:pharmacokinetics*; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D012417:Rumen / Q000378:metabolism*; D012756:Sheep / Q000378:metabolism*
chemical_list: D000871:Anthelmintics; D015766:Albendazole; C027186:albendazole sulfoxide